Can serum SCUBE1 levels be useful in the diagnosis of bladder cancer?

Authors : Ahmet MENTEŞE, Selim DEMİR, Serap OZER YAMAN, Diler US ALTAY, Evren FİDAN, Ersagun KARAGÜZEL

Pages : 525-529

View : 42 | Download : 6

Publication Date : 2022-03-18

Article Type : Research Paper

Abstract :Bladder cancer insert ignore into journalissuearticles values(BC); is the most common malignancy of the urinary system and the sixth most prevalent cancer in both men and women. There is currently no biomarker identified to facilitate the diagnosis of BC and which can be considered as the gold standard. The aim of this study was to determine the diagnostic significance of serum signal peptide-CUB-EGF domain-containing protein 1 insert ignore into journalissuearticles values(SCUBE1); levels in patients newly diagnosed with BC and to compare the sensitivity and specificity of SCUBE1 with those of carbonic anhydrases IX insert ignore into journalissuearticles values(CAIX);, which has previously been shown to be positive in BC. SCUBE1 and CAIX levels were investigated using enzyme-linked immunosorbent assay insert ignore into journalissuearticles values(ELISA); in serum samples from 19 patients with bladder cancer and 25 healthy peers. Levels of both were significantly higher in the BC group compared with the control group insert ignore into journalissuearticles values(p=0.0001);. Based on ROC analysis, SCUBE1 emerged as a sensitive test, similarly to CAIX, for identifying BC. These findings suggest that increased SCUBE1 levels may be a useful addition to clinical findings of disease in the diagnosis of BC patients.
Keywords : Bladder cancer, Carbonic anhydrase, SCUBE1

ORIGINAL ARTICLE URL